🇪🇺 GEFAPIXANT in European Union

GEFAPIXANT (GEFAPIXANT) regulatory status in European Union.

Marketing authorisations

EMA

  • Application: EMEA/H/C/005476
  • Local brand name: Lyfnua
  • Status: approved

EMA

  • Application: EMEA/H/C/005884
  • Marketing authorisation holder: Merck Sharp & Dohme B.V.
  • Local brand name: Gefzuris
  • Indication: Treatment of refractory or unexplained chronic cough.
  • Status: withdrawn

Read official source →

GEFAPIXANT in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is GEFAPIXANT approved in European Union?

Yes. EMA has authorised it; EMA has authorised it.

Who is the marketing authorisation holder for GEFAPIXANT in European Union?

Marketing authorisation holder not available in our data.